These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 9380130

  • 1. Treatment of rheumatoid arthritis with a tumor necrosis factor receptor-Fc fusion protein.
    Epstein WV.
    N Engl J Med; 1997 Nov 20; 337(21):1559-60; author reply 1560-1. PubMed ID: 9380130
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of rheumatoid arthritis with a tumor necrosis factor receptor-Fc fusion protein.
    Mannik M, Wener M.
    N Engl J Med; 1997 Nov 20; 337(21):1560; author reply 1560-1. PubMed ID: 9380131
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.
    Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, Ettlinger RE, Cohen S, Koopman WJ, Mohler K, Widmer MB, Blosch CM.
    N Engl J Med; 1997 Jul 17; 337(3):141-7. PubMed ID: 9219699
    [Abstract] [Full Text] [Related]

  • 4. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.
    Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ.
    N Engl J Med; 1999 Jan 28; 340(4):253-9. PubMed ID: 9920948
    [Abstract] [Full Text] [Related]

  • 5. Anticytokine therapy in rheumatoid arthritis.
    Firestein GS, Zvaifler NJ.
    N Engl J Med; 1997 Jul 17; 337(3):195-7. PubMed ID: 9219708
    [No Abstract] [Full Text] [Related]

  • 6. [Anti-TNF-alpha-treatment of arthritis--4-year follow-up].
    Petri A, Dreyer L, Danneskiold-Samsøe B, Terslev L, Bliddal H.
    Ugeskr Laeger; 2003 Nov 24; 165(48):4649-52. PubMed ID: 14677465
    [No Abstract] [Full Text] [Related]

  • 7. Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein.
    Zhou H.
    J Clin Pharmacol; 2005 May 24; 45(5):490-7. PubMed ID: 15831771
    [Abstract] [Full Text] [Related]

  • 8. Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein, Ro 45-2081 (lenercept): results of a dose-finding study in rheumatoid arthritis.
    Furst DE, Weisman M, Paulus HE, Bulpitt K, Weinblatt M, Polisson R, Zaug M, Kneer J, Van der Auwera P, Stevens RM.
    J Rheumatol; 2003 Oct 24; 30(10):2123-6. PubMed ID: 14528504
    [Abstract] [Full Text] [Related]

  • 9. Etanercept in rheumatoid arthritis.
    Ferraccioli GF, Di Poi E.
    N Engl J Med; 1999 Jun 24; 340(25):2000-1. PubMed ID: 10383275
    [No Abstract] [Full Text] [Related]

  • 10. Two-year follow-up in an early rheumatoid arthritis patient treated with etanercept: radiological involvement despite clinical remission.
    Laganà B, Picchianti Diamanti A, Germano V, Argento G, Ferlito C, D Amelio R.
    J Biol Regul Homeost Agents; 2008 Jun 24; 22(4):271-3. PubMed ID: 19036231
    [Abstract] [Full Text] [Related]

  • 11. The anti-TNF revolution in ankylosing spondylitis: patients with severe disease now have access to promising new drugs.
    Schachna L.
    Med J Aust; 2004 Nov 15; 181(10):529-30. PubMed ID: 15540959
    [No Abstract] [Full Text] [Related]

  • 12. Tumor necrosis factor inhibitors: new options for treating rheumatoid arthritis.
    Moreland LW.
    Isr Med Assoc J; 2001 Sep 15; 3(9):686-90. PubMed ID: 11574988
    [Abstract] [Full Text] [Related]

  • 13. USAN Council. List No.407. New names. Lenercept.
    Clin Pharmacol Ther; 1998 Aug 15; 64(2):234. PubMed ID: 9758530
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of 2 doses of etanercept (50 vs 100 mg) in active rheumatoid arthritis: a randomized double blind study.
    Johnsen AK, Schiff MH, Mease PJ, Moreland LW, Maier AL, Coblyn JS, Helfgott SM, Leff JA, Weinblatt ME.
    J Rheumatol; 2006 Apr 15; 33(4):659-64. PubMed ID: 16482646
    [Abstract] [Full Text] [Related]

  • 15. Taiwan experience with etanercept in juvenile rheumatoid arthritis.
    Lai JH.
    J Microbiol Immunol Infect; 2005 Dec 15; 38(6):451-4. PubMed ID: 16341348
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.
    Mease PJ, Hobbs K, Chalmers A, El-Gabalawy H, Bookman A, Keystone E, Furst DE, Anklesaria P, Heald AE.
    Ann Rheum Dis; 2009 Aug 15; 68(8):1247-54. PubMed ID: 18678578
    [Abstract] [Full Text] [Related]

  • 19. TNF-alpha-targeted therapy in rheumatoid arthritis.
    Wendling D, Toussirot E.
    Rev Rhum Engl Ed; 1999 Apr 15; 66(4):187-91. PubMed ID: 10339773
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.